Prophase Labs
PRPH----
Prophase Labs (PRPH)
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnost...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Prophase Labs Analyst Rating
View MoreForecast & Rating
Feb 26, 2025Price forecast
$138.00229900.00%
Forecast & Rating-
0analysts
News
- Global Report · 18 hours ago
Niche US Assets Catch Fire: Inside the Latest Moves from Sezzle to Sol Strategies
- TradingView · Jun 30 at 04:01 PM
ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q Summary
- Quartr · Jun 30 at 03:53 PM
PRPH: Net loss widened to $5.4 million amid revenue decline and ongoing liquidity challenges
- PUBT · Jun 30 at 03:51 PM
ProPhase Labs Q1 FY26 operating loss widens to $5.4 million; revenue drops 64.29% to $0.5 million
- TradingView · Jun 1 at 04:15 PM
ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K Summary
- StockTitan · Apr 15 at 12:05 AM
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform | PRPH Stock News
